The integration of GLP-1 based treatments with other gut hormone actions offers a promising future in managing obesity and its associated diseases more effectively
There are also no validated dosing guidelines for DSIP, which compounds the risk: an unvalidated dose paired with a product of unverified identity is a poor foundation for any clinical decision
Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor
Zhou YX, Zhang H, Peng C (2014) Puerarin: a review of pharmacological effects
Symptoms of MCAS can include abdominal pain, nausea, itching, flushing, hives, headaches, heart palpitations, anxiety, brain fog, and anaphylaxis